Jean-Marc Huet, Bristol-Myers Squibb EVP and CFO, will leave the company at year’s end, to be replaced on an interim basis by Charles Bancroft, most recently VP of finance for BMS’s global biopharma business. Bancroft will continue to report to Lamberto Andreotti, president and COO, the firm said.